Literature DB >> 2159679

Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers.

E Gonczol1, J Ianacone, W Z Ho, S Starr, B Meignier, S Plotkin.   

Abstract

Three human cytomegalovirus (HCMV) seronegative individuals were immunized with a single dose of HCMV envelope; two individuals developed neutralizing antibodies. Two naturally HCMV seropositive and three HCMV seronegative human volunteers were immunized with a major glycoprotein complex, gA/gB, of HCMV that had been purified by immunoadsorbent column chromatography. After a single injection of the gA/gB preparation, the naturally seropositive individuals developed higher titres of neutralizing antibodies and temporarily higher HCMV-specific lymphocyte proliferation (HCMV-LP) responses in vitro. The seronegative individuals developed neutralizing antibodies after the third injection of gA/gB, which were present only transiently, but showed a rapid reappearance and increase in titre after the fourth injection. At 1 year after the first injection, the neutralizing antibody titres were still comparable with those of the naturally seropositive individuals. HCMV-LP responses to HCMV in the initially seronegative individuals developed after the second or third injection with the gA/gB preparation and remained positive during the 1-year observation period. These results show that the gA/gB protein induces both humoral and cellular immune responses in humans, and might serve as the basis of a subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159679     DOI: 10.1016/0264-410x(90)90135-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Preventing Infection by Human Cytomegalovirus.

Authors:  Stanley A Plotkin
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

2.  The Status of Vaccine Development Against the Human Cytomegalovirus.

Authors:  Stanley A Plotkin; Dai Wang; Abdel Oualim; Don J Diamond; Camille N Kotton; Sally Mossman; Andrea Carfi; David Anderson; Philip R Dormitzer
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

3.  Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression.

Authors:  S Pepperl; J Münster; M Mach; J R Harris; B Plachter
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 4.  The history of vaccination against cytomegalovirus.

Authors:  Stanley Plotkin
Journal:  Med Microbiol Immunol       Date:  2015-03-20       Impact factor: 3.402

5.  Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.

Authors:  K D Greis; W Gibson; G W Hart
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 6.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

7.  Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

Authors:  Felix Wussow; Flavia Chiuppesi; Joy Martinez; John Campo; Erica Johnson; Christin Flechsig; Maegan Newell; Elaine Tran; Jose Ortiz; Corinna La Rosa; Andreas Herrmann; Jeff Longmate; Rana Chakraborty; Peter A Barry; Don J Diamond
Journal:  PLoS Pathog       Date:  2014-11-20       Impact factor: 6.823

Review 8.  Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development.

Authors:  Giuseppe Gerna; Daniele Lilleri
Journal:  Vaccines (Basel)       Date:  2020-04-23

Review 9.  Where do we Stand after Decades of Studying Human Cytomegalovirus?

Authors:  Francesca Gugliesi; Alessandra Coscia; Gloria Griffante; Ganna Galitska; Selina Pasquero; Camilla Albano; Matteo Biolatti
Journal:  Microorganisms       Date:  2020-05-08

Review 10.  Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice.

Authors:  Sara Scarpini; Francesca Morigi; Ludovica Betti; Arianna Dondi; Carlotta Biagi; Marcello Lanari
Journal:  Vaccines (Basel)       Date:  2021-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.